EVE TAYLOR PA56PROFESSIONAL
TOLIFE
GP pharmacists in the spotlight
Latest floorplan & exhibitor list
ALLY CLINICD CARE FOCUSEATRE THE
PB10
SPECIAL PRODUCTS
PB22
ADLENS
CAL SHORELINE MEDI REFRIGERATION
PB15
AYMES
PC20
PB16
NATIONAL ECZEMA
PC18
PC10
PC1
REAL WORLD RETAI
SPECIALS LAB
SOCIETY
PC3
PB25 NOVA MEDICAL LTD SOLUTIONS
AEPC UK
HD MEDI
SWEDSAFE
PE11
PC42
Sponsored
HOT PHARMA
CDRX METHAMEASURE AND
PRICEGRI
by
PE50
PF10 INFIRST
PRECISION ROBOPHARMA B.V. MARKETING GROUP
PF1
PF25
CAMRX LTD
PG11
PG10
PF5
DOMETIC UK LTD
FREZYDERM UK
PG12
PG15
PG13
PF7
SYNMED RX
PF8
HUTCHINGS CONSULTANTS
PH13ShopRX
red by
Sponso
INTERNATIONAL
PJ10 STEROPLAST
HEALTHCARE
CSY RETAIL
PJ3
MHRA
PJ14 KEGELCORE VIA
PJ20
PJ19
PK14 PK15 PK10 PK12 REG COSTCO ATS ACCOUNTANTS TEAM PRE WHOLESALE
RA ACCOUNTANTS
PJ24 MEDIHOLDINGS
PJ25
ROBOSOL SOFTWARE
HOLD
WHAT SKIN NEEDS
LIPOTRIM
PK20
PK23
SHOPFI AND INTERIORS
HOLD
PJ40 PDT SOLICITORS PJ43 PJ42 ECOGEN
PJ45
AKL
PK45 PK40SHAWBROOK PHARMACY BAUSCH & LOMB UK PK30 PK35 FINANCE
HELIX HEALTH
RUSHPORT LLP ADVISORY
PH63 PH65
MEDEPOS BREASTLIGHT
PJ65
PH62
ZIPPO UK
GROSVENOR
PJ66
PH60A® GEL PH62A QED SCIENTIFIC
BRAY HEALTHCARE
SILICOL
LIFEPLAN
PJ60
PG MUTUAL
PJ57
PJ65
WESTLAB PURE NG MIAB MINERAL BATHI NGTONS PJ59 PENNI MANCHES LLP
PJ69 TA COMVI
DAY LEWIS
PK48
ROCK TAPE
PK50 PK49 NEILMED LLOYDS BANK PLC
PK51
SUPERDRUG
PK52
PK55
PINDERS
EDUCATION HUB
PG81
COSMEBEL
PG82 G QCI
MEDISCA
RAPEED
PG80
PJ68
PH70
PH72
NATURES AID
E M PHARMA
PH80
PH81
PB82
NSONS UK TETENAL PARKI
YNOTE THE KE E THEATR d by Sponsore
GENERAL PHARMACEUTICAL COUNCIL
ADA MASSAGE PJ46 INCHAI RS
PJ35 WELOCUM VINTAGE COSMETICS SOLE PJ33 PJ34 VELRESCO MATES PHARM BERLINGER CLARI & CO AG LABORATOIRE
A. VOGEL
PH61
ATTENDS
PH54
PJ55
PJ50 PHARMA NORD UK
P&S
ALS
BIODERMA UK
LEC
PH60
LIQUID IWANTGREATCARE SKIN
PH52
IPS SPECIALS
PJ30 ROSKERR PJ35A PJ36
PG66
ASHN
PH53 TRADE JS PH55 PH56
WELL PHARMACY
LENIZER
M CUBED CHARTERED ACCOUNTANTS
PG55
PH51
PH50
FRIO UK
PF82
PF85
CLINIGEN GROUP
PG65
BODYGLOVE
PG52
PF80
ETHIGEN
PG75 PG73 PHYNOVA SCIENCE OF SKIN PG76 KNIGHTS FRAGRANCES PG74 PG72 PG71 SEA BAND
PG70
PG69
PG60
PG56
ENTEROMED
SALUS
PH32
PJ32 PJ31 APPROVED TTING ATL SYSTEMS
PJ26 SILVER LEVENE PHARMACY PJ27 PJ22 THECONSULTANCY
BY ATTI
PHOTO ME
PJ12 FORTUNA HEALTHCARE
MY LOCUM CHOICE
PJ5
PJ11
RB CAFÉ
PF73
PF75
KENT PHARMACEUTIC
RED CROSS PG53 PG54 BIOTECH BRITISH RED IND CROSS
AHA
PH35
PH30
SAVEO SCAN RB UK
CHRISTIE & CO
BSN MEDICAL
LABORATOIRE LISANDRA
CIG
PG51
SIAN TRADING
ACTIVA
PHARMACY GY HEALTHCARE TECHNOLO HUB PH29
PH14
PH15
PJ1
PHARMACIST ENOCH EVANS SUPPORT
STRATHCLYDE ALS PHARMACEUTIC
PH20 TIANA
SAINT COME LABOTATORIES
PF9 IMMUTEST PH8
PG45
PG32
PG31
PG28
MEDIWIN
PH11
PH12
PH10
EPOS LOGIC
PG38
PG30 RAPID PHARM AL
NUMARK
LEXON
MEDICARE EUROPE LTD
NATIONAL PHARMACY ASSOCIATION
PG50
PG22 ROYAL PHARMACEUTIC SOCIETY
O’KEEFFE’S COMPANY
PFIZER
PF61
HOLD
EMT
OMRON
WOMAKE
METRO HEALTH & BEAUTY
OREUS UK
VYPE E - CIGARETTES
PG20
PD88
HOLD
PF60 CY S PSNC PHARMA SERVICEION INNOVAT THEATRE
PF33
CLOVER 51 WILLACH PHARMACY SOLUTIONS
PF18
PF16
PE74
SOMATOX
PF70
E
PF55
PF40
PF32
PF30 PF29
PF20
FORUM
& Health
Diagnostics
PE71
PD87
PE73 Abundance
PE72Hibergene DENWARD
MAIN AISL PF50
LTD SPLAT GLOBAL UK
APTEKA
SPEECHLYS
PE62
PE65
PROFOOT
PD86
PD77 PD76A PD76 PD79 NATURES PLUS PD78A CHARLES RUSSELL LLP
ALS
PE60
M+N TRADERS
PD81 DREAM NATURES PD84
LETSGETCHECKELIDTTLE SUNFLOWER CREAM TRUSTY INTRAPHARM MY PREP FOR PRE REG PD78 READSPEX
SIGMA
CAREFUSION
PF15
PD80 OIR
PD73 PD75 MEDICALERT
PD71 ALTACOR
BSK Medical
THEA PHARMACEUTIC
CEGEDIM RX
PE10
E
HOLD
PD66
SCANLITE
PB84
PD72 AVANOR HEALTHCARE
PE70
PE42
OMNICELL
MAIN AISL
PD69
Salcura
UHY ECO VAPE UK HACKER YOUNG
VMI CARE
NORLAND SOLUTIONS
DOOR STEP PHARMACY
PD65
PB82
INDIV
PD67 PD68 SCRATCH SLEEVES
Lease UK
NICOCIGS
ACTIVE MINDS
DX
INTELLIGENT CANDY
S COCOA PD74 PD70 PALMER' BUTTER BRAND STUART
SKINS SEXUAL HEALTH
PE61
PE45
PE40 PE30
PE21
ARRA GROUP
ES ZHEJIANG MEDICIN & HEALTH PRODUCTS
NING
PD60
PB81
VALLEY PC72 PC75 SUNDRIES SAVANTINI PC78
PC77
SCIENTIA SKILLS
PD65 PD63
PD62
GSK VACCINES TRAI
UK
PC72
The Royal ColandlegeChiofld Health Paediatrics
PD61
KESTREL
LTD
SILVERHAIRFOIL.CO
PC70 ISAGI LTD
LTD
MYLAN EPD
PD55 PD56
PURESSENTIEL
PB80 SJH RETAIL DESIGN
PB79 PB78 PB74 UK WOGAN PB72 AMG WEALTH DUDLEY HUNTLease M MANAGEMENT
LOGIXX PHARMA
Eco Bath Company
NET1ON1 WHOLESALE PC67 TY LTD PRIME FIF PC64 PC65 CPPE PC61 Complete PC69 PC68 Pharmacy Regent PC62 PC60 Pharmaceuticals MPUA
ORDERWISE
CLINOVA
EASTSTONE SPECIALS
PB65
OXFORD PHARMACY STORE NHS
PHILIPS ELECTRONICS
PD54
PD50
PD48
PD42
PD35
HRA PHARMA
PB64
PB70
PB63 CO LTD MEDI PB61 MAX PB62 AVIELA PHARMA BROTHER PB68 LTD
PB60 E
PD52
PERSPIREX
PURESSENTIEL
SCOPE GROUP
BAYER
PD53
PD51
PD46
PD40
DERMASEL
PD32 D
PB59
HEALTH PUBLIC LBEING & WEL
CITYSPRINT HEALTHCARE
MULTIMEDS AND CAREMEDS
VIP LOUNGE
PE20
PE13
PE12 ROYAL BRUSH
Sponsore
SEE PAGES 6 - 7
THE TENS+ SESDERMA COMPANY
KPB CONSULTING
MERIAL
PE3
LABCOLD
PC38
BODYWEAR LTD
PD21
PONT PACKAGING
PE1
PC36
ALIUM
JEI DANIEL BIOTECH CORP
SWAINS
NUTRICA EARLY LIF NUTRICIA ADVANCED N MEDICAL NUTRITIO
BBI HEALTHCARE
PC48
PC46
PC40 PC41
In associatio
PB56
PB54 PB58
PB52
EPSOM FLEMING MEDICAL SALTS
RANT RESTAU FÉ & CA
PRACTICEHUB PHARMACY n with
PA58 HEALTHAID LTD
KAYS MEDICAL
LIFEVAC EUROPE LTD
WATERJEL EUROPE
VMD
SMART SYRINGA ORGANIC SOLUTIONS
PB53
PB50
PB44 LLP PB47 SUKRIN PB45 PB48
PB41
RBS
PB43 PB42
PD30
ROBOTIK TECHNOLOGY
PD11 GSK
PE5
R VISITO CE ENTRAN d by
SEE PAGE 3
PC32
MARTINDALE
PHARMAPOD DOSE
PD10
PB40
ÖSSUR
HARPER ADAMS
PRODUCTS
PANCREATIC ON CANCER ACTI
PC24
PD20
PD13
LOCATE A LOCUM
PC33 PC30 PC31 BOTT LTD UK
PC28
HSCIC CHIESI
PD12
DR. BEE
PB28
PC22
L
QUEEENS BELFAST UNIVERSITY HEALTH CHECK SERVICES
PB21
PB20
PA44 PIVOTELL PA37 PA40 A & D MEDICAL PA31 PA33 TALL NATURES KNOWI INTERNATIONAL DREAM LOYALTY SYSTEMS GLAUCOMA PB33 E PB38 ASSOCIATION HEALTHERA PB31 MICROLIF PB30 BATHING PB36 CWP BEAUTY PB39 UDDERLY SMOOTH EAR PB34 PB37 LTD CAFLON PB32 PIERCING LTD WISDOM RE HEALTH KUEHNE + NAGEL TOOTHBRUSHES NSPI
PA32 DIVACUP PA26 PA30 TRAVEL JOHN
PA24 TY PA22 ERSI ‘N PA20 NICE-PAK INT. LTD UNIOFVBRADFORD PA10 MANE TAIL PROPHARMA ES MEDICAL SUPPLI
PA54 TECHNOLOGIES PA50 PA52TRAINING PA46 PA49 DURBIN PREMIER HEALTH ECG
ESL
CLEMENT CLARKE
Pfizer Healthy Partnerships in Community Pharmacy SEE PAGES 8
Not to scale. to change. of print. Subject the time Correct at
PK25 BR FOODS
PHARMACY SUN MEDICAL PATCH
CY PHARMA ESS BUSINTR E THEA
THE SPOTLIGHT IS ON PHARMACY. don’t BE left in the dark... d by
Sponsore
B U TC H E R
www.thepharmacyshow.co.uk
@pharmacyshow
The Pharmacy Show Network
Support your local pharmacy campaign sets new records Written by Ian Strachan, Chairman of the NPA
What is the impact of Brexit on community pharmacy? This is the question on the minds of many of our members. The uncertainty and questions around how Brexit will play out mean it’s difficult to answer this question. In the coming weeks and months, as things hopefully become clearer, we’ll be shedding more light on what the result will mean for the sector. You can be certain that there will be a significant impact. No sector of UK industry or public service will be unaffected.
So, what now? It’s great that The Mirror, The Daily Telegraph and the Sunday Express have all come out openly in support of the campaign. It is important to build up from this high water mark of editorial support, including by reinforcing the national coverage with local media activity. The aim must be to raise awareness of the personal consequences the current DH proposals would inflict on patients. Public sympathy is beginning to translate into organised representations from patient groups and citizen groups, especially groups representing older people. This is a very helpful development, which officials and Ministers would be foolish to ignore. Crucially, there must be constructive talks with DH about alternatives to their strategy. It must surely be possible to make the pharmacy sector and the health system overall more efficient, whilst ensuring that no patient is left behind. So, the 24 May is a day to look back on with satisfaction and pride (more info at youtube.com/ watch?v=B8h4fmQxgkM). On that day it was made abundantly clear that the Department of Health has underestimated how people feel about local pharmacies and has not thought through the implications of its policies for those patients and communities in greatest need.
PSNC calls for full EPS to be fine-tuned Proposals to take the Electronic Prescription Service (EPS) into its next phase during 2016/17 cannot be completed until “a number of agreed prerequisites are addressed”, PSNC has told pharmacy contractors in England. This development phase aims to develop full EPS functionality, and will see mandatory nominations removed, PSNC has told contractors. However, pharmacists are advised to still give patients “the opportunity to benefit from using nomination”, PSNC EPS lead Daniel Ah-Thion has said. In a briefing to pharmacy contractors PSNC notes the intention for NHS England to move to a system where most prescriptions are sent via EPS by default, and the nomination requirement removed. In the GP contract for 2016-17 in England, GPs are urged to aim for at least 80 per cent of repeat prescriptions transmitted electronically using EPS by 31 March 2017.
In other news, we recently (24th May) presented the monumental Support Your Local Pharmacy campaign petition to Downing Street – 1.8 million signatures. The petition has broken all UK records for the level of support it has attracted. It could not have been achieved without the commitment and respect of patients and the public. Nor could it have happened without the determination pharmacists have displayed over the past few months. Coinciding with the closing date of the formal DH consultation, a parliamentary briefing attracting 50 MPs and a lively debate in the House of Commons, it was a defining moment. But it was not a finishing line. The momentum is with us in the campaign against the Department of Health proposals and we must press on.
July 2016
Once complete, the new phase will see GPs issue tokens where no nomination is set, and paper prescriptions used, for example, when requested by the patient or for drugs not coded for use in the EPS.
NPA Chairman Ian Strachan But it is far more important to look forward, and to keep the momentum going in the right direction. We are duty bound to continue making the case for a sustainable future for local pharmacies – on behalf of all those patients who have supported us and who rely on pharmacies to meet a wide range of care needs. It’s safe to say there are challenging times ahead. So, the NPA will be pressing ahead to launch business solutions to help members with their financial bottom line. Come and speak to us at the Pharmacy Show (stand PF50) to find out about the ways in which we can support you with resources that help you to examine your pharmacy business, protect you against financial loss and develop new sources of income. Let me leave you with some of the great stories that pharmacists have shared about the great work day in day out they have been doing. You can share yours at npa. co.uk/step-forward. “A patient complained of serious abdominal pain and wanted some advice on taking painkillers. Upon questioning, I ruled out minor problems. I suspected appendicitis but as the pain was moving, I could not be 100% so I advised her to go to A&E. She came into the pharmacy a few weeks later and told me I had saved her life. She had an ectopic pregnancy which could have burst and potentially, she could have died.” Divyakant Mazny, Nu-Ways Pharmacy, Middlesex.
Continued on p3
PSNC says it has reviewed the proposals for this latest phase and has identified a number of issues that must be dealt with prior to the completion: improved system resilience and business continuity for contractors; improved smartcard access and further action to tackle direction of prescriptions. “PSNC believes that the prerequisites and additional issues need to be successfully addressed in order to reduce the risk and adversely affect [on] the experiences of patients, pharmacy teams and other NHS stakeholders. “We are working with NHS England and the Health and Social Care Information Centre (HSCIC) to ensure that these issues are addressed as quickly as possible,” contractors have been told. In addition, the (HSCIC) which masterminds the EPS programme, has called for enhanced pharmacy system supplier EPS agreements, pharmacy training and provisions to allow electronic prescribing and dispensing of controlled drugs. As of June 6, 2016, 81 per cent of GP practices are live with the EPS, and 19 million patients have set an EPS nomination. It is estimated that 44 per cent of total prescriptions in England were claimed by EPS in April 2016. The EPS has been in operation since 2007. In its response to Prescription for Excellence, Community Pharmacy Scotland said: “The community pharmacy network cares for approximately 600,000 patients every week in Scotland. Often these pharmacies are situated in the heart of deprived areas. In the majority of cases a generalist community pharmacist will be able to manage most patients for the majority of time.”
Register for your free place today at www.thepharmacyshow.co.uk/newspaper Media partners
Supported by
Charity partner